Pharmacogenomic landscape of Indian population using whole genomes-Reference-Cited by-同舟云学术

Pharmacogenomic landscape of Indian population using whole genomes

Published:2022-03-26 Issue:4 Volume:15 Page:866-877
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Sahana S.¹²,Bhoyar Rahul C.¹,Sivadas Ambily³,Jain Abhinav¹²,Imran Mohamed¹²,Rophina Mercy¹²,Senthivel Vigneshwar¹²,Kumar Diwakar Mohit¹²,Sharma Disha¹,Mishra Anushree¹,Sivasubbu Sridhar¹²,Scaria Vinod¹²

Affiliation:

1. CSIR Institute of Genomics and Integrative Biology New Delhi India

2. Academy of Scientific and Innovative Research (AcSIR) Ghaziabad India

3. Division of Nutrition St. John’s Research Institute St. John’s National Academy of Health Sciences Bangalore India

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13153

Reference46 articles.

1. The genetic basis of variability in drug responses

2. Pharmacogenomics: Precision Medicine and Drug Response

3. Pharmacogenomics and Personalized Medicine

4. Center for Drug Evaluation & Research.Table of pharmacogenomic biomarkers.https://www.fda.gov/drugs/science‐and‐research‐drugs/table‐pharmacogenomic‐biomarkers‐drug‐labeling(2020).

5. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines.https://cpicpgx.org/guidelines.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementing pharmacogenetic testing to optimize proton-pump inhibitors use among Indian population based on CPIC-CYP2C19-PPI dosing guidelines: The need of the hour;Indian Journal of Pharmacology;2024-07

2. A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care;The Pharmacogenomics Journal;2024-03-15

3. Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives;Frontiers in Public Health;2024-03-14

4. Ethnic differences in pharmacogenomic variants: a south Asian perspective;Pharmacogenomics;2024-03

5. Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population;BMJ Open Diabetes Research & Care;2024-03